AzTrials
AzTrials

Sedentary LifestlyeNCT07309263

Comparing the Effects of Smart App-Assited Super-Slow Jogging and Stationary Cycling on Respiratory Function and Aerobic Fitness in College Students

A study testing Super slow jogging and moderate exercise training in people with Sedentary Lifestlye and Young Adult, run by Fooyin University at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Sedentary Lifestlye, Young Adult
What is being tested?
Super slow jogging and moderate exercise training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteTaiwan
Study dates
20 Nov 2025to 28 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • required no regular exercise training in the past six months
  • ability to safely perform high-intensity cycling exercise

Who cannot join

  • musculoskeletal limitations that prevented cycling exercise
  • recent infection
  • known cardiopulmonary disease or medical history affecting cardiovascular or respiratory function
  • smoking
  • use of medications that may influence cardiopulmonary responses to exercise
  • other contraindications to exercise testing according to the American College of Sports Medicine (ACSM) guidelines

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • No. 151, Jinxue Rd.

    Kaohsiung City, Daliao, 831301

Other trials in Taiwan

About this study

As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Against a backdrop of prolonged sitting and inactivity, "super slow jogging" is gaining attention. This aerobic exercise involves a slow walking pace and low intensity, yet burns more calories than regular walking, making it an ideal entry-level activity for beginners or those with lower fitness levels. This study aims to investigate whether incorporating super slow jogging training can effectively enhance cardiorespiratory fitness and respiratory function, comparing its outcomes with other exercise types. The purpose of this experiment is academic research, primarily exploring the impact of exercise intervention on physiological functions. It is not intended for health screening or medical diagnosis.

Being tested
Super slow jogging, moderate exercise training, Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Super slow joggingBehavioural

    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

    Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

    Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

    Control Group: No exercise training intervention.

  • moderate exercise trainingBehavioural

    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

    Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

    Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

    Control Group: No exercise training intervention.

  • ControlBehavioural

    This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

    Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

    Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

    Control Group: No exercise training intervention.

Study groups in NCT07309263
Study groupRoleWhat they receive
Super slow joggingExperimentalA smart app will provide pacing assistance, adjusting step frequency weekly: Week 1: 150 steps per minute Week 2: 180 steps per minute Week 3: 190 steps per minute Week 4: 200 steps per minute
Receives: Behavioral: Super slow jogging
moderate exercise trainingExperimentalContinuous cycling training at moderate intensity of 60% VO₂max
Receives: Behavioral: moderate exercise training
ControlPlacebo comparatornot perform any exercise training
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiopulmonary Fitness

    VO2max (ml/kg/mL)

    Measured: Before intervention and the end of intervention at 12 weeks

  2. Baseline anthropometric of the participants

    Age (yr)

    Measured: Before intervention and the end of intervention at 12 weeks

  3. Cardiopulmonary Fitness

    VEmax (L/min)

    Measured: Before intervention and the end of intervention at 12 weeks

  4. Cardiopulmonary Fitness

    AT% (%VO₂max)

    Measured: Before intervention and the end of intervention at 12 weeks

  5. Cardiopulmonary Fitness

    Resting O₂ pulse (mL·beat-¹)

    Measured: Before intervention and the end of intervention at 12 weeks

  6. Cardiopulmonary Fitness

    Max O₂ pulse (mL·beat-¹)

    Measured: Before intervention and the end of intervention at 12 weeks

  7. Cardiopulmonary Fitness

    MIP (cmH2O)

    Measured: Before intervention and the end of intervention at 12 weeks

  8. Cardiopulmonary Fitness

    MEP (cmH2O)

    Measured: Before intervention and the end of intervention at 12 weeks

  9. Baseline anthropometric of the participants

    Height (cm)

    Measured: Before intervention and the end of intervention at 12 weeks

  10. Baseline anthropometric of the participants

    Weight (kg)

    Measured: Before intervention and the end of intervention at 12 weeks

  11. Baseline anthropometric of the participants

    BMI (kg/m²)

    Measured: Before intervention and the end of intervention at 12 weeks

Secondary outcomes (8)
  1. Lung function

    FEV1 (L)

    Measured: Before intervention and the end of intervention at 12 weeks

  2. Lung function

    FVC (L)

    Measured: Before intervention and the end of intervention at 12 weeks

  3. Lung function

    FEV₁/FVC (%)

    Measured: Before intervention and the end of intervention at 12 weeks

  4. Lung function

    FEF25-75% (L·s-¹)

    Measured: Before intervention and the end of intervention at 12 weeks

  5. Lung function

    PEF (L·min-¹)

    Measured: Before intervention and the end of intervention at 12 weeks

  6. Lung function

    MVV (L·min-¹)

    Measured: Before intervention and the end of intervention at 12 weeks

  7. Lung function

    Breathing reserve (%)

    Measured: Before intervention and the end of intervention at 12 weeks

  8. Lung function

    Dynamic Index (DI%)

    Measured: Before intervention and the end of intervention at 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2025
  2. Study start20 Nov 2025
  3. Primary completion31 Jan 2026
  4. Study completion28 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07309263
Sponsor's protocol ID
114-0561
Other IDs
114-2813-C-242-003-B
Status last verified
Sep 2026
First submitted
21 Nov 2025
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Super slow jogging and moderate exercise training in people with Sedentary Lifestlye and Young Adult, run by Fooyin University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiopulmonary Fitness (time frame: Before intervention and the end of intervention at 12 weeks). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in